Published in Lab Law Weekly, June 10th, 2005
The issuance of these two patents on May 3, 2005, has also resulted in Heska's overall patent portfolio hitting and exceeding the milestone of 200 U.S. issued patents.
Heska provides innovative high quality diagnostic and therapeutic products to the companion animal allergy market that are supported by its substantial intellectual property portfolio.
That patent portfolio also includes claim scope covering human allergy diagnostic and therapeutic products which has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly